Your browser doesn't support javascript.
loading
Diagnostic performance and clinical implications of rapid SARS-CoV-2 antigen testing in Mexico using real-world nationwide COVID-19 registry data.
Bello-Chavolla, Omar Yaxmehen; Antonio-Villa, Neftali Eduardo; Fernández-Chirino, Luisa; Guerra, Enrique C; Fermín-Martínez, Carlos A; Márquez-Salinas, Alejandro; Vargas-Vázquez, Arsenio; Bahena-López, Jessica Paola.
Afiliação
  • Bello-Chavolla OY; División de Investigación, Instituto Nacional de Geriatría, Mexico City, Mexico.
  • Antonio-Villa NE; MD/PhD (PECEM), Faculty of Medicine, National Autonomous University of Mexico, Mexico City, Mexico.
  • Fernández-Chirino L; Faculty of Chemistry, National Autonomous University of Mexico, Mexico City, Mexico.
  • Guerra EC; MD/PhD (PECEM), Faculty of Medicine, National Autonomous University of Mexico, Mexico City, Mexico.
  • Fermín-Martínez CA; MD/PhD (PECEM), Faculty of Medicine, National Autonomous University of Mexico, Mexico City, Mexico.
  • Márquez-Salinas A; MD/PhD (PECEM), Faculty of Medicine, National Autonomous University of Mexico, Mexico City, Mexico.
  • Vargas-Vázquez A; MD/PhD (PECEM), Faculty of Medicine, National Autonomous University of Mexico, Mexico City, Mexico.
  • Bahena-López JP; MD/PhD (PECEM), Faculty of Medicine, National Autonomous University of Mexico, Mexico City, Mexico.
PLoS One ; 16(8): e0256447, 2021.
Article em En | MEDLINE | ID: mdl-34464393
ABSTRACT

BACKGROUND:

SARS-CoV-2 testing capacity is important to monitor epidemic dynamics and as a mitigation strategy. Given difficulties of large-scale quantitative reverse transcription polymerase chain reaction (qRT-PCR) implementation, rapid antigen tests (Rapid Ag-T) have been proposed as alternatives in settings like Mexico. Here, we evaluated diagnostic performance of Rapid Ag-T for SARS-CoV-2 infection and its associated clinical implications compared to qRT-PCR testing in Mexico.

METHODS:

We analyzed data from the COVID-19 registry of the Mexican General Directorate of Epidemiology up to April 30th, 2021 (n = 6,632,938) and cases with both qRT-PCR and Rapid Ag-T (n = 216,388). We evaluated diagnostic performance using accuracy measures and assessed time-dependent changes in the Area Under the Receiver Operating Characteristic curve (AUROC). We also explored test discordances as predictors of hospitalization, intubation, severe COVID-19 and mortality.

RESULTS:

Rapid Ag-T is primarily used in Mexico City. Rapid Ag-T have low sensitivity 37.6% (95%CI 36.6-38.7), high specificity 95.5% (95%CI 95.1-95.8) and acceptable positive 86.1% (95%CI 85.0-86.6) and negative predictive values 67.2% (95%CI 66.2-69.2). Rapid Ag-T has optimal diagnostic performance up to days 3 after symptom onset, and its performance is modified by testing location, comorbidity, and age. qRT-PCR (-) / Rapid Ag-T (+) cases had higher risk of adverse COVID-19 outcomes (HR 1.54 95% CI 1.41-1.68) and were older, qRT-PCR (+)/ Rapid Ag-T(-) cases had slightly higher risk or adverse outcomes and ≥7 days from symptom onset (HR 1.53 95% CI 1.48-1.59). Cases detected with rapid Ag-T were younger, without comorbidities, and milder COVID-19 course.

CONCLUSIONS:

Rapid Ag-T could be used as an alternative to qRT-PCR for large scale SARS-CoV-2 testing in Mexico. Interpretation of Rapid Ag-T results should be done with caution to minimize the risk associated with false negative results.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Teste Sorológico para COVID-19 / SARS-CoV-2 / COVID-19 / Antígenos Virais Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Teste Sorológico para COVID-19 / SARS-CoV-2 / COVID-19 / Antígenos Virais Idioma: En Ano de publicação: 2021 Tipo de documento: Article